Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Depreciation & Amortization (CF) (2016 - 2025)

Utah Medical Products has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $212000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $212000.0 for Q4 2025, up 6.0% from a year ago — trailing twelve months through Dec 2025 was $826000.0 (up 13.15% YoY), and the annual figure for FY2025 was $826000.0, up 13.15%.
  • Depreciation & Amortization (CF) for Q4 2025 was $212000.0 at Utah Medical Products, up from $209000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for UTMD hit a ceiling of $212000.0 in Q4 2025 and a floor of $149000.0 in Q1 2022.
  • Median Depreciation & Amortization (CF) over the past 5 years was $158000.0 (2021), compared with a mean of $171350.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 8.59% in 2022 and later soared 30.97% in 2024.
  • Utah Medical Products' Depreciation & Amortization (CF) stood at $153000.0 in 2021, then increased by 3.27% to $158000.0 in 2022, then changed by 0.0% to $158000.0 in 2023, then increased by 26.58% to $200000.0 in 2024, then increased by 6.0% to $212000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $212000.0 (Q4 2025), $209000.0 (Q3 2025), and $205000.0 (Q2 2025) per Business Quant data.